跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BIO-FLUOXETINE
Authorized
STANDARD
BIO-FLUOXETINE
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cd5edb0742044e36
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
cd5edb0742044e36
Drug Approval Canada Name
BIO-FLUOXETINE
Product Name
BIO-FLUOXETINE
Status
Marketed
Status Date
2024-12-05
Original Market Date
2016-10-25
Din
02448432
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB03 FLUOXETINE
Atc Name
n 06 ab 03
Aig Number
0116847001
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
FLUOXETINE (FLUOXETINE HYDROCHLORIDE)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cd5edb0742044e36
Type
Standard
Back to Health Canada Approvals
BIO-FLUOXETINE - Health Canada Drug Approval Details